A Staged Phase 3 Study, Including a Double-Blinded Controlled Stage to Evaluate the Safety and Immunogenicity of Ad26.ZEBOV and MVA-BN-Filo as Candidate Prophylactic Vaccines for Ebola
Phase of Trial: Phase III
Latest Information Update: 24 Mar 2017
At a glance
- Drugs Ad26 EBOV vaccine (Primary) ; Modified Vaccinia Ankara Bavarian Nordic Ebola Marburg vaccine
- Indications Ebola virus infections
- Focus Adverse reactions; Pharmacodynamics
- Acronyms EBOVAC-Salone
- Sponsors Janssen Vaccines and Prevention
- 21 Mar 2017 Planned number of patients changed from 728 to 1019.
- 20 Feb 2017 Planned End Date changed from 1 Feb 2019 to 1 May 2019.
- 15 Nov 2016 Last checked against Pan-African Clinical Trials Registry record.